Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Ovarian Neoplasms 86Breast Neoplasms 68Triple Negative Breast Neoplasms 32Prostatic Neoplasms 32Fallopian Tube Neoplasms 25Neoplasms 23Neoplasm Metastasis 21Pancreatic Neoplasms 18Endometrial Neoplasms 18Small Cell Lung Carcinoma 13Carcinoma, Ovarian Epithelial 11Carcinoma, Non-Small-Cell Lung 10Stomach Neoplasms 9Sarcoma 9Recurrence 9Lung Neoplasms 9Fanconi Anemia, Complementation Group D1 9Squamous Cell Carcinoma of Head and Neck 8Glioma 8Parkinson Disease 4, Autosomal Dominant Lewy Body 7Glioblastoma 7Colorectal Neoplasms 6Metastatic Castration-resistant Prostate Cancer 5Lymphoma, Non-Hodgkin 5Cholangiocarcinoma 5Carcinoma, Renal Cell 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Solid Tumors 4Osteosarcoma 4

Interventions

Fulvestrant 18Letrozole 8Anastrozole 6Capecitabine 5palbociclib 4olaparib 4Paclitaxel 4Goserelin 4Docetaxel 4pyrotinib 3exemestane 3Injections 3toripalimab 2sacituzumab govitecan 2ribociclib 2eribulin 2elacestrant 2abemaciclib 2Vinorelbine 2Trastuzumab 2FCN-437c 2Everolimus 2Dasatinib 2Aromatase Inhibitors 2Alpelisib 2Albumin-Bound Paclitaxel 2AZD9833 2vandetanib 1trastuzumab deruxtecan 1talazoparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Advanced Breast Cancer × olaparib × Clear all
NCT05536128 2025-04-17

Post-CDK

Seoul National University Hospital

Phase 2 Recruiting
64 enrolled
Breast

Advanced Breast Cancer

NCT03205761 2024-10-18

COMETABreast

Spanish Breast Cancer Research Group

Phase 2 Completed
11 enrolled 20 charts
Breast

Advanced Breast Cancer

NCT03931551 2023-02-22

OPHELIA

MedSIR

Phase 2 Terminated
5 enrolled
Breast

Advanced Breast Cancer

NCT03182634 2019-01-22

plasmaMATCH

Institute of Cancer Research, United Kingdom

Phase 2 Unknown
1,150 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡